首页> 外国专利> Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as SGLT inhibitors and process for their manufacture

Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as SGLT inhibitors and process for their manufacture

机译：氨基葡萄糖取代的环丙基苯衍生物，包含此类化合物的药物组合物，其作为SGLT抑制剂的用途及其制备方法

页面导航

摘要
著录项
相似文献

摘要

Glucopyranosyl-substituted cyclopropyl-benzene derivatives defined according to claim 1, including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.

机译：根据权利要求 1的定义的葡糖基糖基取代的环丙基苯衍生物，包括互变异构体，其立体异构体，其混合物及其盐。根据本发明的化合物适合于治疗代谢紊乱。 展开▼

著录项

公开/公告号US8039441B2

专利类型

公开/公告日2011-10-18

原文格式PDF

申请/专利权人 FRANK HIMMELSBACH;MATTHIAS ECKHARDT;PETER EICKELMANN;
展开▼

申请/专利号US20070377217

发明设计人 FRANK HIMMELSBACH;MATTHIAS ECKHARDT;PETER EICKELMANN;
展开▼

申请日2007-08-14

分类号A01N43/04;A61K31/70;C07H1;

国家 US

入库时间 2022-08-21 18:13:13

相似文献

专利

外文文献

中文文献

1. N-取代的氨基苯并环庚烯、氨基四氢化萘、氨基茚满和苯烷基胺衍生物、包含所述衍生物的药物组合物及其在治疗中的用途 [P] . 中国专利： CN104011028A . 2014-08-27

2. 一类取代哌嗪类化合物、其制备方法、用途及包含此类化合物的药物组合物 [P] . 中国专利： CN101318943A . 2008-12-10

3. GLUCOPYRANOSYL-SUBSTITUTED CYCLOPROPYLBENZENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS, THEIR USE AS SGLT INHIBITORS AND PROCESS FOR THEIR MANUFACTURE [P] . 美国专利： US2010179191A1 . 2010-07-15

机译：葡糖基糖基取代的环丙基苯衍生物，包含此类化合物的药物组合物，其作为SGLT抑制剂的使用及其制备方法

4. GLUCOPYRANOSYL-SUBSTITUTED CYCLOPROPYLBENZENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS, THEIR USE AS SGLT INHIBITORS AND PROCESS FOR THEIR MANUFACTURE [P] . 欧洲知识产权局专利： EP2054426A1 . 2009-05-06

机译：葡糖基糖基取代的环丙基苯衍生物，包含此类化合物的药物组合物，其作为SGLT抑制剂的使用及其制备方法

5. GLUCOPYRANOSYL-SUBSTITUTED CYCLOPROPYLBENZENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS, THEIR USE AS SGLT INHIBITORS AND PROCESS FOR THEIR MANUFACTURE [P] . CA2656847A1 . 2008-02-21

机译：葡糖基糖基取代的环丙基苯衍生物，包含此类化合物的药物组合物，其作为SGLT抑制剂的使用及其制备方法

1. Tracing manufacturing processes using blockchain-based token compositions [J] . Martin Westerkamp, Friedhelm Victor, Axel Küpper 数字通信与网络（英文） . 2020,第002期

2. New Process for Manufacture of Ethylbenzene Via Non-Ethylene Route Developed by Danyang Chemical ＆ Pharmaceutical Design and Research Institute [J] . 无中国炼油与石油化工：英文版 . 2009,第002期

3. The Evolving State of Continuous Processing in Pharmaceutical API Manufacturing: A Survey of Pharmaceutical Companies and Contract Manufacturing Organizations [J] . J. Christopher McWilliams, Ayman D. Allian, Suzanne M. Opalka, Organic process research & development . 2018,第9期

4. Monitoring volatile compound profiles and chemical compositions during the process of manufacturing semi-fermented oolong tea. [J] . Lin S. Y., Chen Y. L., Lee C. L., The Journal of Horticultural Science & Biotechnology . 2013,第2期

5. Quality by design approach of a pharmaceutical gel manufacturing process, part 2: Near infrared monitoring of composition and physical parameters [J] . Juan G. Rosas, Marcel Blanco, Josep M. Gonzalez, Journal of pharmaceutical sciences. . 2011,第10期

6. Electrochemical Impedance Evaluation of Uracil and Thymine Pyrimidine Derivatives and its Nucleosides Compounds as a Non-toxic Corrosion Inhibitors of Steels in 1M HCl [C] . Araceli Espinoza-Vazquez, Guillermo E. Negron-Silva, Deyanira Angeles Beltran, MES 26: Electrochemistry as a tool for sustainable development . 2011

7. Manufacture of Individualized Dosing: Development and Control of a Dropwise Additive Manufacturing Process for Melt Based Pharmaceutical Products [D] . I?ten, El?in. 2016

8. Impact of the Allowed Compositional Range of Additively Manufactured 316L Stainless Steel on Processability and Material Properties [O] . Felix Großwendt, Louis Becker, Arne Röttger, 2021

9. Studies on Inclusion Compounds. III. : Interaction of beta;-Schardinger Dextrin with Pharmaceuticals. (2). : Investigation of Solubilizing and Stabilizing Effects to Barbituric Acid Derivatives (Pharmaceutical) [O] . KYOKO KOIZUMI, KAZUKO FUJIMURA 1972

10. Processing and Problems in Manufacturing MJR Billets of Four Separate Compositions for Lawrence Livermore National Laboratory [R] . McDonald, W., Smathers, D. B., O'Larey, P. M., 1985

1. Tracing manufacturing processes using blockchain-based token compositions [J] . Martin Westerkamp ,Friedhelm Victor ,Axel Küpper . 数字化用户：数字通讯 . 2020,第002期

2. Hydrothermal Processing,Characterization and Theoretical Calculations of a Copper（Ⅱ） Compound with 1,10-Phenanthroline Derivative Ligand：2-（4-Methoxyphenyl）-1H-imidazo4,5-f1,10 Phenanthroline [J] . HUANG Yan-Ju ,NI Liang ,ZHU Yan-Yu . 结构化学 . 2012,第003期

3. Treatment of pharmaceutical wastewater containing recalcitrant compounds in a Fenton-coagulation process [J] . Bukuru Godefroid . 环境科学学报：英文版 . 2006,第3期

4. 含吡唑环的双杂环化合物研究H2-取代苯氧乙硫基-5-吡唑基-1,3,4-恶二唑和双(5-吡唑基-1,3,4-恶二唑-2-)二硫代烷烃的合成及生物活性 [C] . . 中国化工学会农药专业委员会第九届年会 . 1998

5. 取代苯氧乙酰硫脲及其稠杂环的研究---含嘧啶杂环的取代苯氧乙酰硫脲和2H-1,2,4-噻二唑并[2,3-a]嘧啶衍生物的合成及除草活性研究 [A] . 郭金山 . 1999